SymlinPen is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Pramlintide Acetate.
| Product ID | 0310-6627_15ee192e-97e1-4867-9b0d-b093b841e939 |
| NDC | 0310-6627 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SymlinPen |
| Generic Name | Pramlintide Acetate |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2015-01-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021332 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | PRAMLINTIDE ACETATE |
| Active Ingredient Strength | 1000 ug/mL |
| Pharm Classes | Amylin Agonists [MoA],Amylin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-01-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021332 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-08 |
| Ingredient | Strength |
|---|---|
| PRAMLINTIDE ACETATE | 1000 ug/mL |
| SPL SET ID: | 4aea30ff-eb0d-45c1-b114-3127966328ff |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-6615 | SymlinPen | pramlintide acetate |
| 0310-6627 | SymlinPen | pramlintide acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYMLINPEN 78301872 3419705 Live/Registered |
AMYLIN PHARMACEUTICALS, LLC 2003-09-17 |